Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
The connected health market will hit $117 billion by 2020 and 86 percent of clinicians believe mobile apps will be central to patient health in that time frame, according to the "State of the App Economy" report from ACT | The App Association.
The University of Southern California Center for Body Computing (CBC), the digital health innovation accelerator for the Keck Medicine of USC medical enterprise, has announced eight foundational partners for its Virtual Care Clinic.
CHIME has sent a letter to the Chronic Care Working Group of the Senate Committee on Finance to develop policies that will enable better healthcare for chronically sick patients.
Dell is the latest company to sign on as an industry collaborator of the HIMSS Innovation Center, joining other major health IT organizations at the 30,000-square-foot testing and exhibition facility in Cleveland.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.